本页面由Tiger Trade Technology Pte. Ltd.提供服务

10x Genomics, Inc.

23.68
-1.0000-4.05%
盘后23.750.0700+0.30%18:57 EDT
成交量:379.88万
成交额:9,171.85万
市值:30.06亿
市盈率:-132.69
高:25.23
开:24.50
低:23.44
收:24.68
52周最高:26.45
52周最低:8.07
股本:1.27亿
流通股本:1.17亿
量比:1.29
换手率:3.25%
股息:- -
股息率:- -
每股收益(TTM):-0.1785
每股收益(LYR):-0.3490
净资产收益率:-2.98%
总资产收益率:-4.48%
市净率:3.69
市盈率(LYR):-67.84

数据加载中...

2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

重要事件披露

Form 8-K - Current report